Navigation Links
Stereotactic Breast Biopsy introduced with Fischer-Giotto Image at American Society of Breast Surgeons course
Date:5/1/2013

CHICAGO, IL (PRWEB) May 01, 2013

Fischer Medical Technologies will work with the educational arm of the American Society of Breast Surgeons (ASBS) by providing the use of the Fischer-Giotto Image for the introductory stereotactic breast biopsy workshop at the upcoming 14th annual ASBS conference. Fischer’s skilled technical staff from the U.S. and Italy will be assisting with the instruction.

The Fischer-Giotto Image is the only prone breast imaging system that uses the same detector during both the mammography exam and the biopsy procedure. This unique feature minimizes the need for additional exposures and dose, while providing superior quality images. The precise correlation of images produced by the dual-use detector provides more confidence, especially in vacuum assisted biopsies of subtle micro-calcifications.

The Fischer-Giotto Image, a FFDM (full-field digital mammography) and stereotactic breast biopsy system, was introduced in the U.S. in 2012. The first installation of the Fischer-Giotto Image was at Boulder Community Hospital, in Boulder, CO, replacing the Fischer Mammotest system. It is receiving enthusiastic reviews from both the physicians and technologists. Additional systems have been installed at Mankato Clinic (MN), Saratoga Hospital (NY) and Derby Family MedCenters (KS).

ASBS’s Stereotactic Breast Biopsy: An Introductory Course is a full-day session geared toward the breast surgeon with little or no prior experience in stereotactic breast biopsy. The course is currently filled to capacity, however, the Fischer-Giotto Image can be seen at the Fischer-Giotto Booth #203, at the ASBS conference, May 1-5, at the Sheraton Chicago Hotel & Towers.

ABOUT FISCHER MEDICAL TECHNOLOGIES
Fischer’s roots go back to 1910, when H.G. Fischer, the oldest manufacturer of X-ray imaging devices in the United States, began its operations in Chicago, IL. Fischer Medical Technologies LLC is based in Broomfield, Colorado and is the successor company to Fischer Imaging. Fischer Medical was formed in 2006 by the original founders of Fischer Imaging following the acquisition of all the assets of Fischer Imaging, including all patents, trademarks, product designs, and 510(k) filings. Fischer’s focus is on developing differentiated technologies to improve imaging systems’ efficiency and effectiveness through innovative and creative designs. Contact info@fischermti.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10680570.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Robert Lowen MD, Expert Bay Area Plastic Surgeon, Announces Cutting-Edge 3-D Crisalix Imaging Technology to Aid Patients in Choosing their Breast Implant Size
2. Patti Flint MD, A Top Female Plastic Surgeon in the Southwest, Is Proud To Offer Cutting-Edge 3D Crisalix Technology to Patients When Selecting Breast Implants
3. Dr. Vasquez at the Connecticut Plastic Surgery Group Now Offers the Unique Crisalix 3D Simulations for Facial Aesthetics and Breast Augmentation
4. QVC and Fashion Footwear Association of New York Invest in Personalized Breast Cancer Therapy Research
5. The First Dedicated Breast Cancer Cell Line Transfection Reagent
6. NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer
7. University of Maryland Breast Cancer Research Pioneer Dr. Angela Brodie Appointed Fellow of New American Association for Cancer Research Academy
8. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
9. Positive Clinical Breast Cancer Data Presented for NuView’s Molecular Imaging Biomarker NLS-VPAC1
10. Frost & Sullivan: Modest Growth Projected in the U.S. Breast Imaging Systems Market Amidst Increasing Breast Cancer Prevalence
11. Transition in cell type parallels treatment response, disease progression in breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing and stem ... for the third quarter and first nine months of ... Third Quarter of Fiscal 2017 Highlights ... by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... 24, 2017  VWR Corporation (NASDAQ: VWR), the leading global ... production customers, today reported its financial results for the fourth ... Highlights: 4Q16 record quarterly net sales ... an organic basis. 4Q16 EMEA-APAC ... basis, while the Americas net sales increased 2.5%, or down ...
(Date:2/23/2017)... -- Financial Highlights ... unaudited)Three Months Ended December 31,Twelve Months Ended December 31,20162015% ... $           300$   ... Product Revenue 3539(10)%9498(4)%Kuvan Net Product ... 756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... JOSE, Calif. , Feb. 23, 2017 /PRNewswire/ ... exclusive license for two key immunotherapy technologies from ... first technology provides a method to monitor a ... such as PD-L1 and CTLA-4.  The second license ... if a patient is likely to have an ...
Breaking Biology Technology:
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
(Date:2/8/2017)... 2017 The biometrics market has reached ... of organizations, desires to better authenticate or identify ... and challenge questions), biometrics is quickly working its ... market is driven by use cases, though there ... enterprise uses cases, with consumer-facing use cases encompassing ...
Breaking Biology News(10 mins):